These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 19219685)
1. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy. George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of RAGE and its ligands in proliferative retinal disease. Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297 [TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657 [TBL] [Abstract][Full Text] [Related]
5. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy. Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065 [TBL] [Abstract][Full Text] [Related]
6. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881 [TBL] [Abstract][Full Text] [Related]
7. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes. Nam DH; Oh J; Roh JH; Huh K Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495 [TBL] [Abstract][Full Text] [Related]
8. Intraocular expression of serum amyloid a and interleukin-6 in proliferative diabetic retinopathy. Ma Y; Tao Y; Lu Q; Jiang YR Am J Ophthalmol; 2011 Oct; 152(4):678-685.e2. PubMed ID: 21704966 [TBL] [Abstract][Full Text] [Related]
9. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy. Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497 [TBL] [Abstract][Full Text] [Related]
10. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635 [TBL] [Abstract][Full Text] [Related]
11. Localisation of opticin in human proliferative retinal disease. Pattwell DM; Sheridan CM; Le Goff M; Bishop PN; Hiscott P Exp Eye Res; 2010 Mar; 90(3):461-4. PubMed ID: 20036236 [TBL] [Abstract][Full Text] [Related]
12. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056 [TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment. Coral K; Angayarkanni N; Madhavan J; Bharathselvi M; Ramakrishnan S; Nandi K; Rishi P; Kasinathan N; Krishnakumar S Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4746-52. PubMed ID: 18566459 [TBL] [Abstract][Full Text] [Related]
14. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Itakura H; Kishi S; Kotajima N; Murakami M Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550 [TBL] [Abstract][Full Text] [Related]
15. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production. Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653 [TBL] [Abstract][Full Text] [Related]
16. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Wang X; Wang G; Wang Y Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381 [TBL] [Abstract][Full Text] [Related]
17. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700 [TBL] [Abstract][Full Text] [Related]
18. Endothelins: regulators of extracellular matrix protein production in diabetes. Khan ZA; Farhangkhoee H; Mahon JL; Bere L; Gonder JR; Chan BM; Uniyal S; Chakrabarti S Exp Biol Med (Maywood); 2006 Jun; 231(6):1022-9. PubMed ID: 16741042 [TBL] [Abstract][Full Text] [Related]
19. C-peptide and retinal microangiopathy in diabetes. Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374 [TBL] [Abstract][Full Text] [Related]
20. Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes. Xu J; Zhong H; Cui L; Lan Q; Chen L; He W; Wu Y; Jiang L; Huang H; Zhao X; Li L; Zeng S; Li M; Xu F Oncotarget; 2017 May; 8(22):35532-35541. PubMed ID: 28402943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]